Unilever reported first-half revenue of €25.62 billion and net profit of €3.3 billion, with sales growth coming in ahead of expectations. Dove soap and Rexona deodorant posted strong volume gains in India and Indonesia, offsetting weakness in the food division and European operations. Management raised its full-year 2026 sales outlook on the back of that outperformance.
A guidance upgrade from a consumer staples giant signals that emerging market demand is holding up despite global macro pressure, which matters for any fund or ETF with consumer staples exposure. The planned spinoff of the food arm, valued at roughly 33 billion pounds, could release hidden value and reshape how the stock is priced relative to peers. Investors in European consumer equities should watch whether the margin drag from food and European operations narrows as the separation progresses.
August 2025: Unilever food arm spinoff timeline update expected. October 2025: Unilever Q3 trading statement. October 30, 2025: European Central Bank rate decision, relevant to European consumer spending outlook.
Full analysis · Subscribers
The deep dive (bull case, bear case, and the data point that decides which side wins), the cause-and-effect chain behind the move, plain-English explainers for every block.
Aggregated reads dozens of sources in five languages and turns the day into plain-English cards like this one.
Educational analysis of public information, not investment advice. Report an error · Corrections policy
← Today's brief